Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. - Wikidata - wikimedia - TriplyDB

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

http://www.wikidata.org/entity/Q36787353

about

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer.Array-based DNA methylation profiling for breast cancer subtype discrimination.Gene promoter methylation is associated with increased mortality among women with breast cancer.Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer DNA methylation and hormone receptor status in breast cancer.RASSF1A Promoter Methylation Levels Positively Correlate with Estrogen Receptor Expression in Breast Cancer Patients.Inherited and acquired alterations in development of breast cancer.Quantitation of CDH1 promoter methylation in formalin-fixed paraffin-embedded tissues of breast cancer patients using differential high resolution melting analysis.The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India.Quantitative assessment of the association between APC promoter methylation and breast cancer DNA methylation as a biomarker in breast cancer.Unique epigenetic gene profiles define human breast cancers with poor prognosis.Epigenetics of estrogen receptor-negative primary breast cancer.Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes.Tumor Heterogeneity in Breast Cancer.RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.Methylation status and protein expression of RASSF1A in breast cancer patients.Gestational oral low-dose estradiol-17β induces altered DNA methylation of CDKN2D and PSAT1 in embryos and adult offspring.The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge

P2860

Q26782613-35F359C2-254B-4D18-8938-E9A74CADF87B Q26783596-97190FB5-69A0-4878-97C3-0E114DB1EF94 Q27694612-361F88C1-4046-4CD2-B9FD-F437BE20C1ED Q28087759-B211F794-0490-4C37-BFA1-D58AA1D98561 Q28269080-14F4FE5B-1E04-46A9-BB1B-A9BCE02D401A Q33570282-3C36E563-454B-4C77-87F5-54E978AEEF67 Q33676758-0C7A984E-6812-405C-91D6-ADDC10703FDC Q33689442-47F093EA-AD8E-4BAD-8B2F-E2437CF68727 Q33848807-68CD7B0D-967B-4694-8761-53C7F8061F76 Q33892868-97BCB2A5-2BB7-4E59-8E91-4FDF0339CCF0 Q34048118-91BE9EAF-F06A-413A-8DDA-C7445F83E9F3 Q34625392-B8746EF5-503E-4546-A073-DDE25120393F Q35008011-8453461D-7F13-45A8-986D-4FDF37ACB8DC Q35958967-2A24A32B-7764-43E4-B3F1-26A195A4A97A Q35989635-BC15173A-4BC3-4109-835F-10ECDEC3D94E Q35993199-63C9A32F-FC90-42D6-9D1A-86D179DF0742 Q36061986-FA84D77D-E2D8-4A73-8868-0C23607B0417 Q36583742-AC7B1EED-83FE-410C-99E9-2BD8F9D7CC4D Q36865048-78C384E9-ADB1-499E-AF2C-E3C8021648AE Q36925229-7BD8E041-F434-4200-AE46-3A16F9A3BA71 Q37006733-930DDB05-4F9D-43F2-9D56-89613A714296 Q37177902-E822BE25-42E9-4B2A-8501-4AF339A9F475 Q37308097-1AA2DA16-17B9-483E-A878-ECBD23B3865D Q37367387-E1B2130B-6D35-4BF3-8DA6-D2006F031566 Q37429833-05F8EE9E-8DE9-4B3F-BECD-3FC7B3722DD7 Q37437350-2C1E21FA-6198-47A9-BC37-635196D2BB59 Q37620392-D3E1C6C7-BBBD-4A8C-AACA-53E15CFDBCF2 Q37699138-C471C5A5-0D77-4378-9DE1-EBCF84C42961 Q38012175-F0B2DF13-E6BC-436C-BA24-45D8AC8D9BE2 Q39287409-9E712C26-0BB5-40BE-AFD2-E31B90395783 Q42367979-433C10BA-5AF6-499B-B3D2-12D6495BACF9 Q42496731-2685AEB8-EE4A-41AC-A9C1-25FD3B0E8694 Q47146956-29F47FE5-3916-4678-A9DA-F23FBEE993AF Q53190494-AE0AE847-53EF-4F16-9F21-37665EDD72B3 Q54484988-4E9EED06-281D-47AE-994B-C2B49FB04D71 Q54569398-A8E9C85D-BCD9-4F95-B3CC-252B9F40D2B6 Q54936274-34F2FA57-AD5A-4908-B0A1-1581B2EA0C9E Q57107038-76D8E243-092B-4126-BCF6-8FFD5B284CA6

P2860

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

http://www.wikidata.org/entity/Q36787353

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Estrogen receptor and HER2/neu ...... enes in primary breast tumors.

@en

type

label

Estrogen receptor and HER2/neu ...... enes in primary breast tumors.

@en

prefLabel

Estrogen receptor and HER2/neu ...... enes in primary breast tumors.

@en

P1433

Q36787353-968776F3-96EE-4CEB-B9BB-074DA96815CA

P1476

Q36787353-73054420-E78C-45A4-BD11-3EF76A3767BE

P2093

Q36787353-2184CF5B-E0D5-4EDD-B7DF-AAEE1156A3C5

Q36787353-2EC8D98E-F223-4DCD-8222-BDA27A5741C0

Q36787353-44801250-777F-4FF8-A44E-B77AD8987C78

Q36787353-5A5A0859-A4CD-49B0-8B95-0D82D48CF6A4

Q36787353-63F54049-CD19-412A-8D18-D6011EDA3444

Q36787353-EFB6F902-4E2C-4C24-A8FF-FE90B8A96C72

P2860

Q36787353-0146FA8A-5FE5-4CEB-82CA-80A43C885CA5

Q36787353-025A3CC8-0F8D-48B9-ABE4-4419D8E637B2

Q36787353-0778807E-DA06-4516-A58C-5EC66D1C1835

Q36787353-0C9FBA58-986D-435A-94EF-880674ECE80C

Q36787353-23F359DA-B2CB-4C12-A9F9-608C1EDF2E7B

Q36787353-2D931456-9FD9-4D39-BC01-6FC542A382AE

Q36787353-2F339419-7EF2-497A-8DC9-E0E85BE6B4F9

Q36787353-32CB4ABD-42D7-4D9E-8EEC-2CAE15B1A1F4

Q36787353-3AC7EECE-B7F3-4B61-8D8F-A58A390C9A2E

Q36787353-431D3C05-0AED-446D-AD17-CD8B3C8DC16B

P2888

Q36787353-243F9994-AB8E-439D-8ACC-D730435AC150

P304

Q36787353-D0D0DB53-F8F0-4F5C-8A3A-60F91F937934

P31

Q36787353-218A5133-57BC-4CEB-9095-7CE8A7C6F798

P356

Q36787353-9F58F4B6-ADB0-4C67-A9F0-AFB110E555D2

P433

Q36787353-999B37B8-8B36-4A94-B00F-86C055C1B235

P478

Q36787353-7C929FB2-A652-4559-8145-8AAB8458A909

P50

Q36787353-6097049F-EE3F-47F2-B372-BBAE94910DAA

P577

Q36787353-B0273604-C481-4E0C-BEDC-14EA2C88154F

P5875

Q36787353-181CF29B-4E7C-4629-8E91-247C6DBF78D0

P6179

Q36787353-FA44FF7E-6779-45DA-ACA0-DB84B2BBC49A

P698

Q36787353-B43F8A5D-7C14-4A85-B2BB-2CDA575FB70C

P932

Q36787353-84A0D1D3-1C9D-400A-8065-7C9B3D280D4A

P356

P1433

Breast Cancer Research

P1476

Estrogen receptor and HER2/neu ...... genes in primary breast tumors

@en

P2093

Anh-Thu Vu

http://www.w3.org/2001/XMLSchema#string

Armando E Giuliano

http://www.w3.org/2001/XMLSchema#string

Eiji Sunami

http://www.w3.org/2001/XMLSchema#string

Masaru Shinozaki

http://www.w3.org/2001/XMLSchema#string

Myung-Shin Sim

http://www.w3.org/2001/XMLSchema#string

Sandy L Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene

Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression

Molecular portraits of human breast tumours

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

The role for NES1 serine protease as a novel tumor suppressor

Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

P2888

P304

R46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2098

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5365798

http://www.w3.org/2001/XMLSchema#string

P6179

1039337121

http://www.w3.org/2001/XMLSchema#string

P698

18485221

http://www.w3.org/2001/XMLSchema#string

P932

2481494

http://www.w3.org/2001/XMLSchema#string